INSM monthly performance report
Monthly INSM research: returns, drawdown, relative strength, seasonality, and key stats.
INSM monthly report
—
Key takeaways
- Insmed Incorporated (INSM) closed August 2026 at $99.02, up 0.43% for the month and −11.28% over the trailing 12 months.
- Year-to-date, INSM is −43.11%, underperforming the S&P 500 which has returned +12.89% YTD.
- The stock is trading −32.84% versus its 200-day moving average ($147.44), a cautious technical signal.
- Over the past three years, INSM has outperformed the S&P 500 by +278.01%, with a relative strength index reading of 265.1.
- Win rate over the trailing 39 months stands at 48.7% — 19 positive months versus 20 negative months.
Insmed Incorporated ended August 2026 at $99.02, posting a monthly return of +0.43%. The S&P 500 returned +3.05% over the same window, leaving relative performance at −2.62%.
The current quarter stands at −8.69% (Q3 2026 (QTD)), while medium-term trend remains soft: price is −32.84% versus the 200-day moving average ($147.44).
Year-to-date, INSM is −43.11% against SPY +12.89%, a gap of −55.99%. The stock is currently −53.46% below its 52-week high, with maximum 3-year drawdown at −56.54%.
| Period | INSM | S&P 500 (SPY) | Excess return |
|---|---|---|---|
| 1 Day | +0.27% | −0.20% | +0.47% |
| 1 Week | −4.91% | +3.90% | −8.81% |
| 1 Month | +0.43% | +3.05% | −2.62% |
| 3 Months | −27.37% | +7.11% | −34.48% |
| 6 Months |